Quarterly Result27 May 2026, 07:52 pm
Johnson Pharmacare Approves Audited Financial Results for FY26
AI Summary
Johnson Pharmacare Ltd's board of directors approved the audited financial results for the quarter and financial year ended March 31, 2026, along with the Independent Auditors Report. The board also took note of the resignations of Mr. Rajendra Prasad (Non-Executive Director) and Mr. Umesh Kumar (Executive Director), both effective April 17, 2026. The meeting was held on May 27, 2026.
Key Highlights
- Board approved audited financial results for the year ended March 31, 2026.
- Rajendra Prasad resigned as Non-Executive Director effective April 17, 2026.
- Umesh Kumar resigned as Executive Director effective April 17, 2026.
- Company confirms Regulation 32 of SEBI (LODR) Regulations, 2015 is not applicable.
Price Impact
More from JOHNPHARMA